Journal of the Louisiana State Medical Society
herpesvirus 8 latent nuclear antigen-1 helps distinguish Kaposi sarcoma from its mimickers. Am J Clin Pathol . 2004;121:335–342. 39. Krown SE, Metroka C, Wernz JC. Kaposi’s Sarcoma in the Acquired Immune Deficiency Syndrome: A Proposal for Uniform Evaluation, Response, and Staging Criteria. J Clin Oncol . 1989;7(9):1201. 40. Krown SE, Testa MA, Huang J. AIDS-related Kaposi’s sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol . 1997 Sep;15(9):3085-92. 41. Grabar S, Abraham B, Mahamat A, et al. Differential impact of combination antiretroviral therapy in preventingKaposi’s sarcoma with and without visceral involvement. J Clin Oncol . 2006 Jul 20;24(21):3408-14. 42. Gallafent JH, Buskin SE, De Turk PB, Aboulafia DM. Profile of patients with Kaposi’s sarcoma in the era of highly active antiretroviral therapy. J Clin Oncol. 2005 Feb 20;23(6):1253-60. 43. Bower M, Nelson M, Young AM, et al. Immune reconstitution inflammatory syndrome associated with Kaposi’s sarcoma. J Clin Oncol . 2005;23(22):5224. 44. Letang E, Lewis JJ, Bower M, et al. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK. AIDS . 2013 Jun;27(10):1603-13. 45. Bower M, Collins S, Cottrill C, et al. British HIV Association guidelines for HIV-associated malignancies 2008. HIV Medicine (2008), 9, 336–388. 46. Kedes DH, Ganem D. Sensitivity of Kaposi’s sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy . J Clin Invest. 1997 May 1;99(9):2082. 47. Steiner B, Aquino VR, Paz AA, et al. Paecilomyces variotii as an emergent pathogenic agent of pneumonia. Case Reports in Infectious Diseases . ID 273848, 3 pp, 2013. doi:10.1155/2013/273848 Dr. Englert is Chief Resident of the Louisiana State University Health Sciences Center Internal Medicine Residency Program. Dr. Seal is Assistant Professor of Medicine at LSUHSC-NO in the section of Infectious Diseases. Dr. Parsons is Associate Professor of Medicine and Microbiology and Director of the HIV Cancer Care Program at LSUHSC – NO. Dr. Arbour is former Chief Resident of LSUHSC-NO Internal Medicine Residency Program. Dr. Roberts III is a Resident in the Tulane University Pathology and Laboratory Medicine Program. Dr. Lopez is a Professor and Vice Chair in the LSUHSC-NODepartment of Medicine.
230 J La State Med Soc VOL 166 September/October 2014
Made with FlippingBook - Online catalogs